Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.43% | 203.20 | 1.2% | $410.88m | |
| GILD | Gilead Sciences, Inc. | 0.29% | 73.88 | 0.9% | $388.27m | |
| CELG | Celgene Corporation | -0.26% | 87.38 | 1.2% | $331.13m | |
| BIIB | Biogen Inc. | 0.60% | 338.91 | 1.2% | $285.04m | |
| ILMN | Illumina, Inc. | -0.15% | 350.37 | 3.5% | $238.24m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.19% | 383.70 | 2.6% | $211.99m | |
| EXAS | Exact Sciences Corporation | 1.90% | 74.14 | 25.3% | $196.59m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.29% | 176.60 | 1.9% | $158.10m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.06% | 151.95 | 16.4% | $124.69m | |
| A | Agilent Technologies, Inc. | 0.93% | 69.57 | 1.5% | $120.73m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.95% | 121.97 | 2.0% | $110.07m | |
| VKTX | Viking Therapeutics, Inc. | 0.98% | 19.65 | 0.9% | $100.12m | |
| NKTR | Nektar Therapeutics | -2.81% | 56.69 | 5.6% | $93.69m | |
| ALNY | Alnylam Pharmaceuticals, Inc | 1.14% | 94.82 | 9.7% | $93.23m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.21% | 99.77 | 4.4% | $92.72m |
Company Profile
Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop innovative, targeted medicines for cancer and other proliferative diseases. The company builds a diversified biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products includes CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.